Amazon talks up AI potential on earnings call, points to limited tariff impact. American Airlines commits to $4 billion ...

Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow ...

Healthify is banking on the rise of GLP-1 weight-loss drugs in India, integrating them with lifestyle coaching. The firm ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

New research has revealed that the injections for weight loss might be doing something much bigger inside your body.

Net loss from continuing operations for the three months ending March 31, 2025 was approximately $4.9 million, or $0.49 per ...

Eli Lilly’s strong quarterly results were overshadowed by CVS’s decision to favour Novo Nordisk’s Wegovy over Zepbound.

Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru Inc. call. An archived version of the audio webcast will be ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...